Barcina Lacosta, Teresa http://orcid.org/0000-0002-6487-2479
Vulto, Arnold G. http://orcid.org/0000-0002-8439-2800
Turcu-Stiolica, Adina http://orcid.org/0000-0003-1374-276X
Huys, Isabelle http://orcid.org/0000-0002-4738-8298
Simoens, Steven http://orcid.org/0000-0002-9512-2005
Funding for this research was provided by:
KU Leuven MABEL Fund
Article History
Accepted: 22 February 2022
First Online: 18 March 2022
Declarations
:
: This study was supported by KU Leuven and by the Fund on Market Analysis of Biologics and Biosimilars following Loss of Exclusivity (MABEL).
: SS, IH and AGV founded the KU Leuven Fund on Market Analysis of Biologics and Biosimilars following Loss of Exclusivity (MABEL). SS was involved in a stakeholder roundtable on biologics and biosimilars sponsored by Amgen, Pfizer and MSD; he has participated in advisory board meetings for Pfizer and Amgen; he has contributed to studies on biologics and biosimilars for Hospira (together with AGV and IH), Celltrion, Mundipharma and Pfizer, and he has had speaking engagements for Amgen and Sandoz. AGV is involved in consulting, advisory work and speaking engagements for a number of companies, a.o. AbbVie, Accord, Amgen, Biogen, Effik Benelux, Fresenius Kabi, Medicines for Europe, Pfizer/Hospira, Mundipharma, Roche, Sandoz. TBL and ATS declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
: The data generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
: Not applicable.
: The interview guide and methodology for this study were approved by the Research Ethics Committee UZ /KU Leuven on the 28th of December 2021 (S64860).
: IH, SS, AGV, and TBL developed the idea for and were involved in the design of this study. ATS and TBL took part in data provision. TBL was involved in data collection and analysis. TBL drafted the initial version of the manuscript. IH, SS, AGV and ATS critically reviewed the manuscript. All authors read and approved the final manuscript.
: Not applicable.
: Informed consent was obtained from all individual participants included in the study.